Today, the Business Secretary Greg Clark has announced that the government is investing over £300 million from its Industrial Strategy Challenge Fund (ISCF) to bring together the UK’s world-class research expertise with business investment to develop technologies and industries that can help the UK prepare for the challenge of an ageing society. £210 million will be invested in the ‘data to early diagnosis and precision medicine’ challenge which will see the UK lead the world in the development of innovative new diagnostic tools, medical products and treatments.
On Friday the Prime Minister announced that the UK will seek to explore with the EU, the terms on which the UK could remain part the European Medicines Agency, abide by the rules of the agency and make an appropriate financial contribution. It’s good to see the PM articulating the practical dynamics of our industry of the future, when she said in her speech that ‘membership of the European Medicines Agency would mean investment in new innovative medicines continuing in the UK, and it would mean these medicines getting to patients faster as firms prioritise larger markets when they start the lengthy process of seeking authorisations.’
BIA welcomes the Prime Minister’s announcement today that the UK will seek to explore with the EU, the terms on which the UK could remain part the European Medicines Agency, abide by the rules of the agency and make an appropriate financial contribution.
This week is set to be a big week for Brexit news as we expect to see key positioning statements from the UK government and the official Labour opposition with a key focus on the customs union. The Prime Minister is expected to speak towards the end of this week following a special Cabinet meeting on Thursday. The speech follows the "war Cabinet" meeting at her country residence Chequers that was held last week to work out a forthcoming Brexit negotiations strategy.
Dr. Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case for promoting greater uptake of maths to support individuals in undertaking the science jobs of today and tomorrow.
This week we are gearing up for our 2018 Committee Summit taking place on Thursday, kindly hosted by Simmons and Simmons. The event will see around 180 expert BIA members gather for all eight of the BIA’s advisory committees coming together. In addition, this year we are running a plenary session on the implications of the Nagoya protocol for our sector.
Thank you to all our members who joined our Brexit lead event last week. It was great to be able to share perspectives on what is a fast moving key issue. I was pleased that members confirmed that we should stay our course on the Brexit priorities agreed last year, which we will keep stressing to the UK government, and with our European partner associations to the EU-27.
Last week saw the launch event for the China Biotech Special Interest Group. We had an excellent turn out at the China-Britain Business Council offices in Victoria, with people coming to hear BIA members talk about their different experiences in China.